Member Announcements 2011

 December 22, 2011

StarFish Medical Honoured to be Included in VIATeC’s Top 25 Technology Companies

December 20, 2011

Biolux Research Announces Appointment of Dr. Tim Shaughnessy to Clinical and Scientific Advisory Board
 

December 14, 2011

Biolux Research Announces New Financing For Development of Light Accelerated Orthodontics Product
 

December 12, 2011

EnWave Signs Research Evaluation Agreement with Merck
 

December 7, 2011

Dr. Diane Finegood appointed MSFHR President and CEO
 

December 6, 2011

Heart Force Medical Inc. Appoints Dr. Jonathan Steinberg to Clinical Advisory Board
 

December 6, 2011

Canadian scientist leading revolutionary approach to tackling forest pests
 

December 6, 2011

Canadian Scientist Leading Revolutionary Approach to Tackling Forest Pests
 

December 6, 2011

SFU scientists help tackle forest pests with genomics
 

December 1, 2011

UBC, CFRI and BC Children’s researchers to lead $2.8-million project to reduce deadly infection in Bangladeshi mothers, children
 

November 29, 2011

New funding ensures bright future for genome science and technology centres in BC
 

November 29, 2011

EnWave Signs Collaboration Agreement with Hormel Foods Corporation
 

November 28, 2011

Tekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial
 

November 25, 2011

UVic-Led Study Reveals Genetic Secrets Of Blueberries
 

November 23, 2011

Salmon genome in final phases of completion
 

November 22, 2011

Sirona Biochem’s French subsidiary receives CDN$1.9-million grant for cosmeceutical project
 

November 18, 2011

Novel Blood Test Identifies Patients with Early Rheumatoid Arthritis; Findings Reported at the American College of Rheumatology (ACR)
 

November 1, 2011

Work Begins on World-Class Isotopes Research Tunnel
 

November 1, 2011

RepliCel Provides Update on First-in-man Clinical Trials and Recent Corporate Activity
 

October 31, 2011

Heart Force Medical Inc. Appoints Vice President of Engineering
 

October 26, 2011

The Rick Hansen Institute and the Canadian Institute for Military & Veteran Health Research partner on unique collaboration to help Canada’s Military and Veterans living with spinal cord injuries
 

October 25, 2011

EnWave Signs Technology Evaluation & License Option Agreement with Ocean Spray Cranberries Inc.
 

October 24, 2011

iCo Therapeutics Oral Amphotericin B Delivery System to be Presented at AAPS
 

October 21, 2011

enGene Inc. Appoints Dr. Richard M. Glickman to the Company’s Board of Directors and Announces Changes to Its Board Composition
 

October 20, 2011

Restoring the “buzz” in honey bee colonies
 

October 20, 2011

Protox Announces the Dosing of Patients in Transrectal Study
 

October 20, 2011

Allon Therapeutics announces completion of patient enrollment in pivotal trial
 

October 19, 2011

Health Canada Approval For Verisante Auraâ„¢ Marks Milestone In Skin Cancer Detection
 

October 19, 2011

New UBC professorship focuses on women’s cardiovascular health
 

October 19, 2011

UBC welcomes $1M boost in entrepreneurship and research translation
 

October 18, 2011

Allegations against UBC researchers’ study on Insite “without merit:” independent reviewer
 

October 15, 2011

TRIUMF Applauds Innovation Award
 

October 3, 2011

Cardiome Updates Corporate Logo and Website
 

September 29, 2011

MSI Methylation Sciences, Inc. Raises EUR13.5 Million From Inventages Venture Capital and Other Investors in Series A Financing
 

September 27, 2011

Lights, camera, action! Gene Screen BC film competition wraps with 19 films
 

September 26, 2011

iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema
 

September 22, 2011

Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs
 

September 21, 2011

Genome BC announces major forestry research initiatives
 

September 20, 2011

BC researchers clearing the way for clean energy from the poplar tree
 

September 15, 2011

EnWave Signs Research & Development Agreement with an Option to License with Bonduelle Canada Inc.
 

September 13, 2011

Wax-it Histology Services Successfully Completes 2 GLP Studies
 

September 2, 2011

GLP Compliant Rodent Toxicology Studies available through the BC Cancer Agency
 

August 29, 2011

Zymeworks Inc. Announces Collaboration with Merck to Develop Bi specific Antibody Therapeutics
 

August 25, 2011

New medical prototypes and diagnostic tools in commercialization pipeline
 

August 22, 2011

RepliCel Names Tom Kordyback Chief Financial Officer
 

August 22, 2011

New MSFHR research awards an investment in the health of British Columbians
 

August 22, 2011

T-cell discovery holds promise for organ transplant and immunodeficiency treatment: UBC research
 

August 19, 2011

Biolux Research Annouces Start of Significant Series of Clinical Trials for Light-Accelerated Orthodontics
 

August 17, 2011

NEOVASC COMPLETES $4.72 MILLION PRIVATE PLACEMENT
 

August 16, 2011

EnWave Announces Positive Monoclonal Antibody Dehydration Test Results using freezeREVâ„¢ Technology
 

August 16, 2011

UBC Researchers Discover Key Mechanism that Regulates Shape and Growth of Plants
 

August 15, 2011

iCo Therapeutics Announces Key iCo-007 Clinical Development Milestone
 

August 12, 2011

Response Biomedical Corporation Announces Resignation of Chief Executive Officer
 

August 11, 2011

Verisante Launches Official Blog and Offers Giveway
 

August 11, 2011

Tekmira Provides Corporate Update and Announces Second Quarter 2011 Results
 

August 10, 2011

OncoGenex to Present at the 2011 Wedbush Securities Life Sciences Management Access Conference
 

August 9, 2011

Sirona Biochem Appoints Dr. Bertrand Plouvier to Vice President, Product Development
 

August 9, 2011

Tekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute
 

August 9, 2011

Baffling disease identified using next generation sequencing tools
 

August 8, 2011

CARDIOME REPORTS SECOND QUARTER RESULTS
 

August 4, 2011

Allon Granted U.S. Patent for Davunetide as a Treatment for Schizophrenia
 

August 4, 2011

Sirona Biochem Proudly Supports Canadian Diabetes Association
 

August 3, 2011

Verisante Engages Manufacturing Partner And Provides Operational Update For Verisante Auraâ„¢ Device For Skin Cancer Detection
 

July 29, 2011

Sirona Biochem Identifies Depigmenting Cosmetic Agent for Cosmeceuticals Portfolio
 

July 28, 2011

Verisante Obtains ISO Certification Of Quality Management System For Medical Device Manufacturing
 

July 28, 2011

QLT’s second-quarter loss widens
 

July 27, 2011

New genetic mutations found for non-Hodgkin lymphoma
 

July 27, 2011

Scientists strike genetic gold in lymphoma study
 

July 26, 2011

Cardiome Consents to Transfer of North American Rights for Vernakalant (IV)
 

July 26, 2011

UBC researchers create more powerful “lab-on-a-chip” for genetic analysis
 

July 25, 2011

The University of British Columbia Studies the Development of ProtoKinetix’ AAGP(TM) Anti-Inflammatory for the $20-Billion Eye Treatment Market
 

July 21, 2011

Neovasc to raise up to $4 million in private placement
 

July 21, 2011

Study Of Proteins Shakes Up Forestry, Medicine
 

July 20, 2011

Verisante Unveils Industrial Design of Verisante Aura
 

July 20, 2011

BioCurex, Inc. Strengthens Management Team and Board of Directors
 

July 19, 2011

New Human Imaging Data Support the Neuroprotective Effects of Allon’s Davunetide
 

July 19, 2011

iCo Therapeutics Engages The Equicom Group
 

July 18, 2011

Protox Secures $15 Million Financing from Oxford Finance LLC
 

July 15, 2011

Verisante Eneters Licensing Agreement For Multi Spectral Imaging Technology To Detect Skin Cancer And Oral Cancer
 

July 15, 2011

Verisante Enters into Asset Purchase Agreement with Perceptronix Medical
 

July 15, 2011

A Courageous Step: The CF Technology Initiative and CDRD move forward in advancing new technologies to help cystic fibrosis patients
 

July 15, 2011

UNBC Scientists Make Technical Breakthrough in Genetics
 

July 14, 2011

Art Reitmayer Joins The Rick Hansen Foundation As Chief Executive Officer
 

July 14, 2011

Newly identified gene mutation linked to Parkinson’s: UBC research
 

July 13, 2011

The Centre for Drug Research and Development (CDRD) and TEC Edmonton join forces to help University of Alberta researchers.
 

July 13, 2011

A Courageous New Step: The CF Technology Initiative
 

July 12, 2011

iCo Therapeutics CMO to Present at The Drug Repositioning Conference.
 

July 12, 2011

an Achilles Heel of Blood Cancers
 

July 7, 2011

James Hatton Advises on Stem Cell License Agreement for Pulmonary Hypertension
 

July 4, 2011

Personalized medicine on the horizon for BC cancer patients
 

June 30, 2011

Boreal Genomics announces the appointment of Nitin Sood to CEO
 

June 29, 2011

UBC researchers invent new drug delivery device to treat diabetes-related vision loss
 

June 28, 2011

Brain and spinal cord injury research gains from funding
 

June 28, 2011

Canada’s Centre for Drug Research and Development and Germany’s Lead Discovery Center Enter into a Partnership to Support the Development of Novel Medicines
 

June 28, 2011

Arrangement Agreement for Privatization of Ondine
 

June 28, 2011

OncoGenex Pharmaceuticals Added to Russell Indexes
 

June 27, 2011

Providence Health Care Research Institute Board of Trustees appoints Ms. Karimah Es Sabar as the new Chair
 

June 27, 2011

LED Medical Diagnostics to Apply Fluorescence Technology to Dermatology Market
 

June 24, 2011

Medical Device Development and Manufacturing Firm, StarFish Medical, Welcomes New Business Development Manager, David Dobson
 

June 24, 2011

iCo Therapeutics Executes Bertilimumab License with Immune Pharmaceuticals
 

June 22, 2011

Ultrasonix Expands North American Sales Management Team
 

June 20, 2011

NEOVASC INC. REPORTS FINANCIAL RESULTS FOR FIRST QUARTER OF 2011
 

June 16, 2011

Tekmira Closes $5.1 Million Public Offering
 

June 14, 2011

UBC researchers discover molecular mechanism for anti-arrhythmia drugs
 

June 14, 2011

EnWave Signs Research & Development Agreement with Kellogg Company
 

June 9, 2011

Tekmira Prices Public Offering
 

June 9, 2011

UBC energy conversion saves $4 million a year, cuts GHGs
 

June 8, 2011

Ondine Biomedical Announces 2011 First Quarter Financial Results
 

June 6, 2011

Allon Therapeutics Wins National Biotech Award
 

June 6, 2011

EnWave Named Early-Stage Industrial Biotechnology Company of the Year
 

June 2, 2011

Protox Reports First Quarter 2011 Financial Results and Achievements
 

May 31, 2011

iCo Therapeutics CEO to Present & Participate in Panel at BioFinance 2011
 

May 24, 2011

Life Sciences in BC gets a Boost from New Partnership
 

May 18, 2011

SIX-MONTH DATA PRESENTED AT EUROPCR SHOW POSITIVE OUTCOMES FOR REFRACTORY ANGINA PATIENT RECEIVING NEOVASC REDUCERâ„¢ DURING TCT 2010
 

May 17, 2011

Tekmira and Bristol-Myers Squibb Expand Collaboration to Include Broader Applications of LNP Technology
 

May 16, 2011

EnWave Signs Commercial Agreement with Milne Fruit Products Inc.
 

May 16, 2011

Cardiome Reports First Quarter Results
 

May 13, 2011

University of Ottawa signs agreement with the Centre for Drug Research and Development (CDRD)
 

May 13, 2011

iCo Therapeutics Inc. Engages Ora for Ophthalmic Clinical & Regulatory Guidance
 

May 12, 2011

Angiotech Pharmaceuticals Announces Final Implementation of Plan of Compromise or Arrangement and Closing of Exchange Offer
 

May 12, 2011

Roche Diagnostics launches the cobas ® 8000 modular analyzer series in Canada at BC Biomedical Laboratories
 

May 11, 2011

Heart Force Medical Inc. Holds Clinical Advisory Board Meeting at HRS
 

May 10, 2011

Tekmira Provides Corporate Update and Announces First Quarter 2011 Results
 

May 10, 2011

Ondine Announces Ventilator Associated Pneumonia (VAP) Photodisinfection Clinical Study in the US
 

May 10, 2011

MAJOR FUNDING BOOST FOR BC-LED CLIMATE CHANGE RESEARCH
 

May 9, 2011

Science student wins best business concept
 

May 9, 2011

RepliCel Completes TrichoScience Acquisition
 

May 6, 2011

BC Scientists Link to European Consortium Studying Human Genome
 

May 6, 2011

UBC adopts grad’s energy makeover project
 

May 5, 2011

University of Calgary Signs Affiliation Agreement with the Centre for Drug Research and Development (CDRD) to Support Preclinical Drug Development
 

May 3, 2011

QLT Announces Positive Results From Phase 1b Trial of QLT091001 in Subjects With Leber Congenital Amaurosis
 

May 2, 2011

OncoGenex to Webcast Discussion of First Quarter Financial Results on Monday, May 9, 2011
 

May 2, 2011

Xenon’s XEN402 Ointment Significantly Relieves Pain in Patients with Post Herpetic Neuralgia
 

May 2, 2011

OncoGenex to Webcast Discussion of First Quarter Financial Results on Monday, May 9, 2011
 

April 29, 2011

iCo Therapeutics Announces Year-End 2010 Financial Results
 

April 28, 2011

SFU chemist among Canada’s Top 40 under 40
 

April 27, 2011

QLT Announces QLT091001 Presentation At ARVO
 

April 27, 2011

Ultrasonix establishes direct sales operations in France
 

April 21, 2011

Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target
 

April 21, 2011

UBC recognizes two Canadian medical researchers with $50,000 prizes
 

April 20, 2011

Making Lemons into Lemonade
 

April 20, 2011

Solegear Secures Strategic Manufacturing Alliances
 

April 19, 2011

MedGenesis Therapeutix Selects SynapCell for Key Preclinical Epilepsy Research
 

April 19, 2011

Sirona Biochem Appoints Dermatology Expert Dr. Stuart Maddin to Scientific Advisory Board
 

April 19, 2011

NSERC Helps Companies and Researchers Engage in R&D
 

April 18, 2011

Protox Announces Move to San Diego and Senior Management Transition
 

April 15, 2011

Ondine to Participate in Vancouver General Hospital Infection Control Quality Improvement Project
 

April 14, 2011

iCo Therapeutics Inc. Secures $10 Million Equity Line Facility
 

April 13, 2011

CDRD-BC Cancer Agency Collaboration Leads to Licensing of Cancer-Fighting Drug Irinophore Câ„¢
 

April 6, 2011

UBC completes landmark deal for dehydration technology
 

April 5, 2011

Angiotech’s creditors approve restructuring plan
 

April 4, 2011

The BCIC-New Ventures Competition: Agritech 2011 Schedule
 

April 4, 2011

UBC announces largest ever gift to Faculty of Medicine: $15M towards Centre for Brain Health
 

April 1, 2011

News Back to main News page
 

April 1, 2011

EnWave Completes Acquisition of Patents from the University of British Columbia and Buyout of Royalty Obligations
 

April 1, 2011

Sirona Biochem Attends Awards Ceremony to Accept TSX Venture Top 50 Award
 

March 31, 2011

Ondine Biomedical Announces 2010 Year End Financial Results
 

March 31, 2011

Protox Reports 2010 Financial Results And Achievements
 

March 31, 2011

Sirona Biochem Acquires TFChem
 

March 31, 2011

Sirona Biochem Appoints Dermatology Expert Dr. Stuart Maddin to Scientific Advisory Board
 

March 30, 2011

Angiotech Pharmaceuticals, Inc. Extends Exchange Offer for Senior Floating Rate Notes
 

March 30, 2011

Tekmira Provides Corporate Update and Reports 2010 Audited Results
 

March 29, 2011

OncoGenex to Present at the Needham & Company 10th Annual Healthcare Conference
 

March 25, 2011

Sirona Biochem Receives TSX-V Acceptance for Acquisition of TFChem and Completes Private Placement of CDN$2,300,000
 

March 23, 2011

Scientists target enzyme and halt spread of deadly breast cancer tumours with novel drugs
 

March 23, 2011

Michael Hayden bestowed premier award for leadership in medicine
 

March 23, 2011

Xenon Chief Scientific Officer, Dr. Michael Hayden Receives Prestigious Award for Leadership in Medicine
 

March 22, 2011

Canadian Scientists Advancing Identification of Rare Disease Genes
 

March 22, 2011

EnWave Begins Testing Continuous Pilot-Scale powderREVTM Dehydration Technology
 

March 21, 2011

Ondine Announces Debt Financing
 

March 18, 2011

North America’s Top Campus Sustainability Project Officially Opens
 

March 18, 2011

Federal Funding Enables CDRD’s Biologics Capabilities
 

March 16, 2011

EnWave Enters into Term Sheet for Purchase of Patents from The University of British Columbia and Buyout of Royalty Obligations Under Existing License Agreements
 

March 11, 2011

Allon announces presentation of davunetide data during 10th International Conference on Alzheimer’s and Parkinson’s Disease
 

March 10, 2011

Cardiome Reports 2010 Results
 

March 8, 2011

BC researchers investigate link between cancers and viruses
 

March 7, 2011

OncoGenex to Webcast Discussion of Fourth Quarter and Full Year 2010 Financial Results on Thursday, March 10, 2011
 

March 4, 2011

Angiotech Pharmaceuticals, Inc. Announces Extension of Exchange Offer and Supplement to Offering Memorandum
 

March 3, 2011

“David and Goliath” viruses shed light on the origin of jumping genes: UBC Study
 

March 1, 2011

Progressive Health Innovations ‘Ready to Rocket’ in 2011
 

February 24, 2011

Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Amend Terms under the Floating Rate Note Support Agreement
 

February 24, 2011

Sirona Biochem Announces Private Placement of CDN$2,500,000
 

February 23, 2011

Local Researchers use Genomics to Investigate TB Outbreak in BC
 

February 23, 2011

Allon Appoints Dr. Michael Gold Chief Medical Officer
 

February 23, 2011

iCo Therapeutics Inc. iCo-007 Program to be Presented & CEO to Sit on Panel at Retinal Physician Symposium 2011
 

February 23, 2011

Kinexus Identifies Over 650,000 Phosphorylation Sites in the Human Proteome
 

February 23, 2011

QLT Chief Medical Officer Steps Down
 

February 23, 2011

Heart Force Medical Inc. Secures Two New Patents
 

February 22, 2011

New genomics research investigates metastatic childhood cancers
 

February 22, 2011

Zymeworks Chief Technology Officer, Dr. Surjit Dixit, to deliver plenary address at NIH sponsored symposium
 

February 22, 2011

Genome BC: New Genomics Research Investigates Metastatic Childhood Cancers
 

February 22, 2011

iCo Therapeutics Inc. Completes iCo-007 Phase 2 Clinical Supply Manufacturing
 

February 22, 2011

Protox Appoints New Directors
 

February 18, 2011

Angiotech Pharmaceuticals, Inc. Announces Execution of Settlement and License Termination Agreement With Rex Medical, LP
 

February 17, 2011

OncoGenex Included in Fast Company Magazine’s Top Ten “Most Innovative Companies” in the Biotech Industry
 

February 16, 2011

Scientists explore link between genes, antisocial behavior and cholesterol
 

February 16, 2011

Neovasc Inc. Named a 2011 Top 50 Company by TSX Venture Exchange
 

February 16, 2011

Genome BC: Scientists Explore Link Between Genes, Antisocial Behavior and Cholesterol
 

February 15, 2011

CDRD Partners with NGDI-UBC to Develop New Interventions for Neglected Global Diseases
 

February 15, 2011

EnWave Named to TSX Venture Top 50 for Second Straight Year
 

February 15, 2011

Sirona Biochem Named to the 2011 TSX Venture 50 Ranking
 

February 14, 2011

SFU researcher wins 2011 E.W.R. Steacie Memorial Fellowship
 

February 14, 2011

UBC Researchers Win National Honours
 

February 11, 2011

Japanese Patent for Allon Therapeutics Progressive Supranuclear Palsy Drug
 

February 10, 2011

Griffith University in Queensland Australia Signs International Affiliation Agreement with the Centre for Drug Research and Development (CDRD)
 

February 10, 2011

Solegear Welcomes Brian Gusko as Incoming CFO
 

February 10, 2011

New Northern-focused Study to Benefit Regional Cancer Survivors
 

February 9, 2011

Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreement
 

February 9, 2011

EnWave Closes CDN$12.0 Million Bought Deal Private Placement
 

February 9, 2011

Allon CEO to Present at BIO CEO & Investor Conference
 

February 9, 2011

Record $22-million Donation Establishes Beedie School of Business at SFU
 

February 8, 2011

NEOVASC Inc. Receives CE Mark for PeriPatch-BVâ„¢ Bovine Pericardial Tissue
 

February 8, 2011

OncoGenex Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
 

February 4, 2011

First Gene Cloned at UBC’s Okanagan Campus
 

February 2, 2011

Allon Announces Davunetide Improves Motor Function and Brain Pathology in a Parkinson’s Disease Model
 

February 2, 2011

Welichem Successfully Completes Two Phase II Clinical Trials of WBI-1001 Cream in Patients with Psoriasis and Atopic Dermatitis
 

February 1, 2011

Sirona Biochem Announces Results of Annual General and Special Meeting and Election of a New Director
 

February 1, 2011

Angiotech Pharmaceuticals, Inc. (ANPI) Announces U.S. Chapter 15 Filings in Connection with Previously Announced CCAA Proceedings
 

February 1, 2011

Fitness Town to Carry AFX
 

January 28, 2011

Angiotech Pharmaceuticals, Inc. to Pursue Completion of Previously Announced Recapitalization Transaction Through CCAA Proceedings
 

January 27, 2011

Neovasc Inc. Issues Incentitice Options to Management
 

January 27, 2011

OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation
 

January 26, 2011

Biolux Research Announces Publication of Research Paper on Phototherapy and Orthodontics
 

January 26, 2011

Angiotech Pharmaceuticals, Inc. Announces Receipt of Notice of Termination From Rex Medical L.P.
 

January 25, 2011

AFX Available at SportMed Retail Locations
 

January 24, 2011

New proteomics technology could detect risk for heart disease and cancer from a single drop of blood
 

January 24, 2011

BC Moves to the Forefront of Medical-Isotope Production Technology
 

January 23, 2011

pr01231101.asp
 

January 21, 2011

New SFU Surrey lab targets biomedical research
 

January 21, 2011

EnWave Completes Warrant Exercise, Generating $2.2M in Cash
 

January 13, 2011

Angiotech Pharmaceuticals Announces Delisting from the Nasdaq stock Market and Transfer to Otcqbâ„¢ Marketplace
 

January 13, 2011

Biolux Research Announces Filing of Two Additional Patent Applications for phototherapy and Orthodontics.
 

January 12, 2011

UBC-Vancouver Coastal Health Researchers Find Critical Link Between Down Syndrome and Alzheimer’s Disease
 

January 10, 2011

Sirona Biochem Announces Positive Preclinical Results for Diabetes Drug Candidate
 

January 6, 2011

UNBC Joins TRIUMF: International Research Excellence Recognized
 

January 5, 2011

Key Executive in BC Life Sciences Joins Genome BC Team
 

January 5, 2011

Allon Enrolling Patients in Pivotal Davunetide Phase 2/3 Trial
 

January 5, 2011

Allon Announces Intention to Draw Down $200,000 From SEDA
 
January 5, 2011
NEOVASC INC. TO PRESENT AT ONEMEDFORUM 2011 FINANCE CONFERENCE
 

January 5, 2011

Southern Interior residents invited to take part in major cancer prevention study
 

January 4, 2011

FDA and Allon Agree on Special Protocol Assessment for Pivotal Trial in Progressive Supranuclear Palsy
 

January 4, 2011

EnWave Announces quantaREVâ„¢, a New High-Capacity Dehydration Technology Platform, and Files Patent